HRTX Market Cap & Key Metrics
Heron Therapeutics, Inc.
$0.36
-$0.03(-7.32%)
49
Overall
40
Value
50
Tech
57
Quality
Market Cap
$68.73M
Volume
2.09M
52W Range
$0.26 - $1.58
Target Price
$2.00
HRTX market cap is $68.73M. This page lists Heron Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
HRTX Key Metrics
- Market cap
- $68.73M
- EPS estimate, current year
- $-0.14
- EPS growth, 3-year
- +58.43%
- Value score
- 40
- Quality score
- 57
- Technical score
- 50
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $154.90M | $144.28M | $127.04M | $107.67M | $86.35M |
| EBITDA | -$7.46M | -$2.58M | -$104.91M | -$190.35M | -$215.25M |
| EPS | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HRTX | $0.36 | -7.3% | 2.09M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Heron Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW